<DOC>
	<DOCNO>NCT00723723</DOCNO>
	<brief_summary>This observational study conduct patient receive statin treatment secondary prevention coronary heart disease current standard care compliance European guideline . The purpose study evaluate percentage patient reach target LDL level . Additionally study measure patient 's compliance treatment assess counting return tablet . Both assessment make visit conduct 6-8 week first visit 28-32 week first visit .</brief_summary>
	<brief_title>Compliance With LDL-Lowering Therapy ( Study P05467 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>willingness participate study 18 year age clinically establish cardiovascular disease consider patient secondary prevention prior therapy statin without achieve goal ( 2.5 mmol/L LDL cholesterol ) last lipid check perform</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>